RIECKERMANN AT DUPHAT 2025
Sharing comprehensive insights into latest pharma industry trends and technologies
Rieckermann was excited to be part of the Dubai International Pharmaceuticals & Technologies Conference & Exhibition (DUPHAT) alongside industry partners De Lama and MG2. The exhibition booth was organized by Rieckermann’s sales team from Jordan and the Middle East Pharma Business Development Manager, Mr. Oliver Lischke. As a dedicated provider of industrial solutions, the company took the opportunity to address key regulatory trends and technological advancements that are currently shaping the pharmaceutical industry. Highlights included:
- Facility design & equipment considerations in line with Annex I: Ensuring compliance with the latest EU GMP Annex I guidelines for sterile manufacturing facilities.
- Latest technology for liquid sterile and oral solid dosage production: Highlighting cutting-edge solutions that enhance efficiency and product quality.
- Intelligent warehouse logistics solutions: Demonstrating advanced logistics systems that optimize storage and distribution processes.
- From ETO to HyPerPure®: Showcasing next-generation sterilization technologies that reduce costs and environmental impact.
- Localizing ready-to-use syringe manufacturing in the Middle East: Exploring strategies to enhance local production capabilities and meet regional demand.
The Rieckermann booth featured representatives from renowned pharmaceutical manufacturers, De Lama and MG2, who provided insights into their latest innovations. Together with the company’s own representatives, the presence of these experts enabled visitors to discover various cutting-edge solutions to meet their unique industrial and regulatory needs. Furthermore, visitors also had the opportunity to explore Rieckermann’s comprehensive engineering solutions and technical services portfolios.
The DUPHAT 2025 show was held from January 7 to 9 at the Dubai World Trade Center, UAE. This unique event presents the entire value chain of the pharma industry, from suppliers of raw materials to manufacturers of formulations, as well as distributors, and pharmacy networks.
